Thursday, July 9, 2026

biotech · ZYBT

Zhengye Biotechnology Holding

Zhengye Biotechnology Holding drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

JILIN, USA HQ
Public company Type
ZYBT · NYSE Ticker
Company details
Status
Public
HQ
JILIN, USA
Programs
0
Drugs
0
Patents
0
Intelligence · Drug Pipeline

Zhengye Biotechnology Holding pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Zhengye Biotechnology Holding drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →